NYSDOH Guidance for Administration of the Second Dose of COVID-19 Vaccine

Lisa Volk and Tarrah Quinlan in Clinical & Quality

There are currently two COVID-19 vaccines authorized for emergency use in the United States: BNT162b2, produced by Pfizer-BioNTech; and mRNA-1273, produced by Moderna. Each of these vaccines have been granted Emergency Use Authorization by the FDA based on a two-dose series. See full guidance here for administration of the second dose of these vaccines.

NYSHFA/NYSCAL CONTACTS:

Lisa Volk, RN, B.P.S., LNHA
Director, Clinical & Quality Services
518-462-4800 x15

Tarrah Quinlan, RN, BSN
Director of Education Program Development and Member Operations
518-462-4800 x20